Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology
- PMID: 26812281
- PMCID: PMC4958598
- DOI: 10.1016/j.jalz.2015.12.006
Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology
Abstract
Introduction: The relationship of diabetes to specific neuropathologic causes of dementia is incompletely understood.
Methods: We used logistic regression to evaluate the association between diabetes and infarcts, Braak neurofibrillary tangle stage, and neuritic plaque score in 2365 autopsied persons. In a subset of >1300 persons with available cognitive data, we examined the association between diabetes and cognition using Poisson regression.
Results: Diabetes increased odds of brain infarcts (odds ratio [OR] = 1.57, P < .0001), specifically lacunes (OR = 1.71, P < .0001), but not Alzheimer's disease neuropathology. Diabetes plus infarcts was associated with lower cognitive scores at end of life than infarcts or diabetes alone, and diabetes plus high level of Alzheimer's neuropathologic changes was associated with lower mini-mental state examination scores than the pathology alone.
Discussion: This study supports the conclusions that diabetes increases the risk of cerebrovascular but not Alzheimer's disease pathology, and at least some of diabetes' relationship to cognitive impairment may be modified by neuropathology.
Keywords: Alzheimer; Autopsy; Cerebrovascular; Cognition; Diabetes; Infarcts; Neuropathology.
Copyright © 2016 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
Figures

References
-
- Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y, Sekita A, Suzuki SO, Kanba S, Kiyohara Y, Iwaki T. Insulin resistance is associate with the pathology of Alzheimer disease: the Hiyasama study. Neurology. 2010;75:764–770. - PubMed
-
- Bonfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel JC, Decker H, Silverman MA, Kazi H, Melo HM, McClean PL, Holscher C, Arnold SE, Talbot K, Klein WL, Munoz DP, Ferreira ST, De Felice FG. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease-associated Aβ oligomers. J Clin Invest. 2012;122:1339–1353. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- K25 AG043546/AG/NIA NIH HHS/United States
- N01 HC005102/HC/NHLBI NIH HHS/United States
- RF1 AG015819/AG/NIA NIH HHS/United States
- M01 RR000334/RR/NCRR NIH HHS/United States
- P01 AG003991/AG/NIA NIH HHS/United States
- P50 AG005681/AG/NIA NIH HHS/United States
- P01 AG026276/AG/NIA NIH HHS/United States
- R01 AG017917/AG/NIA NIH HHS/United States
- U01 AG019349/AG/NIA NIH HHS/United States
- P30 AG008017/AG/NIA NIH HHS/United States
- P30 AG010161/AG/NIA NIH HHS/United States
- R01 AG038651/AG/NIA NIH HHS/United States
- I01 CX000462/CX/CSRD VA/United States
- U01 AG017155/AG/NIA NIH HHS/United States
- R01 NS084965/NS/NINDS NIH HHS/United States
- N01 AG042149/AG/NIA NIH HHS/United States
- P30 AG028383/AG/NIA NIH HHS/United States
- R01 AG015819/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical